BioSpace News Archive

FDA

Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device

Comaneci - the only non-vessel-occluding temporary intracranial coiling embolization assist device

May 7, 2019
·
2 min read
Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

Pi-Cardia Ltd., announced that it successfully completed the First-in-Human studies with its Leaflex™ Performer catheter.

May 7, 2019
·
3 min read
BioCapital

New from NSTA Press: An Updated Guide to Doing Science Well With Young Children

A newly expanded resource from NSTA Press helps teachers build on children’s innate curiosity through 89 activities in life, Earth, and physical science.

May 7, 2019
·
2 min read
Business

Gaurav Sharma Joins as Therapeutic Area Leader, Rare Disease and Oncology

Expands Worldwide Clinical Trials’ Oncology Franchise

May 7, 2019
·
4 min read
BioForest

TransformativeMed Closes $5.8 Series A to Redefine How Clinicians Use the EHR to Communicate and Collaborate

TransformativeMed announced that it has closed a $5.8M Series A financing round led by the Alliance of Angels.

May 7, 2019
·
3 min read
Genetown

Corindus Equips the World’s First Fully Robotic Catheterization Laboratory

Chesapeake Regional Medical Center installs CorPath® GRX Vascular Robotic Systems in all catheterization labs

May 7, 2019
·
7 min read
Drug Development

Repair Biotechnologies Raises $2.15M Seed Round to Develop Drugs for Age-Related Diseases

Repair Biotechnologies, Inc. announced $2.15 million in seed venture funding, to accelerate the preclinical development of its pipeline of drugs targeting thymus regeneration, cancer, and atherosclerosis.

May 7, 2019
·
2 min read
Business

Diplomat Announces 1st Quarter Financial Results

1st Quarter Revenue of $1,257 Million, compared to $1,342 Million, Net Loss of $14.3 Million, compared to a Net Loss of $0.5 Million, Adjusted EBITDA of $23.1 Million, compared to $39.6 Million

May 7, 2019
·
12 min read
Business

Insmed Reports First Quarter 2019 Financial Results and Provides Business Update

ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Net Product Sales $21.0 Million for the First Quarter of 2019

May 7, 2019
·
22 min read
Pharm Country

Analysis Showed Oral Ozanimod Reduced Brain Volume Loss Across All Age Subgroups in Adults with Relapsing Multiple Sclerosis

Data from new analysis of pivotal ozanimod trial will be presented at 2019 AAN Annual Meeting

May 7, 2019
·
7 min read